Boehringer Ingelheim

For Healthcare Professionals

Logout

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Oncology

Respiratory

Inflammation
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Giotrif

Giotrif

Format

Sort by

Reset all filters

PDF

SEREAL||GioTag, the 1st global study to show feasibility of sequential therapy with GIOTRIF® followed by osimertinib

Download Opens in new tab

PDF

SEREAL||Japan real world evidence supports sequential treatment with the use of upfront 2nd generation TKI

Download Opens in new tab

4:13

RWDRI||GIOTRIF® in Uncommon Mutation - A database analysis of >1000 NSCLC Patients

Watch now Opens in new tab

PDF

RWDRI||Real-World First-Line GIOTRIF® for EGFRM+ NSCLC: Updated Survival Data from Korea

Download Opens in new tab

PDF

RWDRI||Vietnam RWD 2024

Download Opens in new tab

PDF

SEREAL||Real-world evidence: GIOTRIF® in Taiwan

Download Opens in new tab

Home
Oncology
Giotrif

Sitemap

Therapeutic Area

Resources

BI logo

Privacy
Terms of use
Sitemap
Contact

This website is intended for healthcare professionals in Singapore. The contents of this website are for information purposes only and are not intended to substitute for advice, treatment or recommendations of a healthcare professional. For your health concerns and other questions about symptoms, treatment or medication, consult a healthcare professional.